{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T07:15:30Z","timestamp":1786864530473,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008975","name":"Universitat de Les Illes Balears","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008975","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Recent preclinical studies have shown sex-dependent antidepressant-like responses of cannabidiol in adolescence, which were dependent on biological sex, early-life stress, and dose. In particular, cannabidiol (10\u00a0mg\/kg) induced acute and sustained antidepressant-like responses in adolescent male rats, while it lacked efficacy in females. This follow-up study aimed at further characterizing cannabidiol\u2019s effects in adolescence, in an attempt to overcome female unresponsiveness, while also evaluating its long-term safety profile in adulthood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Groups of adolescent rats of both sexes were treated (<jats:italic>ip<\/jats:italic>) with cannabidiol (10, 30, 60\u00a0mg\/kg) or vehicle (1\u00a0ml\/kg) for 7 days. Acute (30\u00a0min post-injection) and repeated (24\u00a0h post-treatment) antidepressant-like responses were measured in the forced-swim test. Brains were collected to evaluate several neurochemical correlates in the hippocampus (CBR1, CBR2, BDNF, and cell proliferation) after adolescent cannabidiol exposure (acute and repeated). Some rats were left undisturbed until adulthood, when long-term effects on cognition were measured in the Barnes maze (short- and long-term memory) or affective-like responses in the forced-swim test. Data was analyzed with two-way ANOVAs (independent variables: sex and treatment).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>While the dose of 10\u00a0mg\/kg of cannabidiol induced antidepressant-like effects in adolescent rats, higher doses had no effect in adolescent rats of both sexes. No changes were observed in any of the hippocampal neuroplasticity markers evaluated. Adolescent cannabidiol exposure did not induce long-term changes in cognitive performance or affective-like behavior.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Overall, our data suggest that adolescent cannabidiol treatment produces dose-dependent antidepressant-like effects of moderate magnitude without compromising long-term cognition in rats.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s43440-025-00750-5","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T01:59:43Z","timestamp":1750039183000},"page":"999-1010","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adolescent cannabidiol treatment produces antidepressant-like effects without compromising long-term cognition in rats"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3159-4783","authenticated-orcid":false,"given":"Laura","family":"G\u00e1lvez-Melero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1602-3908","authenticated-orcid":false,"given":"Itziar","family":"Beruete-Fresnillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6684-1214","authenticated-orcid":false,"given":"Sandra","family":"Ledesma-Corvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9177-3775","authenticated-orcid":false,"given":"M. Julia","family":"Garc\u00eda-Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"750_CR1","doi-asserted-by":"publisher","first-page":"107085","DOI":"10.1016\/j.phrs.2024.107085","volume":"201","author":"S Ledesma-Corvi","year":"2024","unstructured":"Ledesma-Corvi S, Jornet-Plaza J, G\u00e1lvez-Melero L, Garc\u00eda-Fuster MJ. Novel rapid treatment options for adolescent depression. Pharmacol Res. 2024;201:107085.","journal-title":"Pharmacol Res"},{"key":"750_CR2","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3390\/biom10111575","volume":"10","author":"MS Garc\u00eda-Guti\u00e9rrez","year":"2020","unstructured":"Garc\u00eda-Guti\u00e9rrez MS, Navarrete F, Gasparyan A, Austrich-Olivares A, Sala F, Manzanares J. Cannabidiol: A potential new alternative for the treatment of anxiety, depression, and psychotic disorders. Biomolecules. 2020;10:1575.","journal-title":"Biomolecules"},{"key":"750_CR3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/ph14121269","volume":"14","author":"GP Silote","year":"2021","unstructured":"Silote GP, Gatto MC, Eskelund A, Guimar\u00e3es FS, Wegener G, Joca SRL. Strain-, sex-, and time-dependent antidepressant-like effects of Cannabidiol. Pharmaceuticals (Basel). 2021;14:1269.","journal-title":"Pharmaceuticals (Basel)"},{"key":"750_CR4","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00213-020-05481-4","volume":"237","author":"C Bis-Humbert","year":"2020","unstructured":"Bis-Humbert C, Garc\u00eda-Cabrerizo R, Garc\u00eda-Fuster MJ. Decreased sensitivity in adolescent versus adult rats to the antidepressant-like effects of Cannabidiol. Psychopharmacology. 2020;237:1621\u201331.","journal-title":"Psychopharmacology"},{"key":"750_CR5","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s43440-021-00285-5","volume":"73","author":"C Bis-Humbert","year":"2021","unstructured":"Bis-Humbert C, Garc\u00eda-Cabrerizo R, Garc\u00eda-Fuster MJ. Antidepressant-like effects of Cannabidiol in a rat model of early-life stress with or without adolescent cocaine exposure. Pharmacol Rep. 2021;73:1195\u2013202.","journal-title":"Pharmacol Rep"},{"key":"750_CR6","doi-asserted-by":"publisher","first-page":"891842","DOI":"10.3389\/fphar.2022.891842","volume":"13","author":"E Hern\u00e1ndez-Hern\u00e1ndez","year":"2022","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez E, Garc\u00eda-Fuster MJ. Dose-dependent antidepressant-like effects of Cannabidiol in aged rats. Front Pharmacol. 2022;13:891842.","journal-title":"Front Pharmacol"},{"key":"750_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s42238-023-00186-9","volume":"5","author":"SE O\u2019Sullivan","year":"2023","unstructured":"O\u2019Sullivan SE, Jensen SS, Nikolajsen GN, Bruun HZ, Bhuller R, Hoeng J. The therapeutic potential of purified Cannabidiol. J Cannabis Res. 2023;5:21.","journal-title":"J Cannabis Res"},{"key":"750_CR8","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11095-023-03469-1","volume":"40","author":"GTY Yau","year":"2023","unstructured":"Yau GTY, Tai W, Arnold JC, Chan HK, Kwok PCL. Cannabidiol for the treatment of brain disorders: therapeutic potential and routes of administration. Pharm Res. 2023;40:1087\u2013114.","journal-title":"Pharm Res"},{"key":"750_CR9","doi-asserted-by":"publisher","first-page":"1448170","DOI":"10.3389\/fphar.2024.1448170","volume":"15","author":"C Colom-Rocha","year":"2024","unstructured":"Colom-Rocha C, Bis-Humbert C, Garc\u00eda-Fuster MJ. Cannabidiol or ketamine for preventing the impact of adolescent early drug initiation on voluntary ethanol consumption in adulthood. Front Pharmacol. 2024;15:1448170.","journal-title":"Front Pharmacol"},{"key":"750_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41398-022-01994-y","volume":"12","author":"S Ledesma-Corvi","year":"2022","unstructured":"Ledesma-Corvi S, Hern\u00e1ndez-Hern\u00e1ndez E, Garc\u00eda-Fuster MJ. Exploring Pharmacological options for adolescent depression: a preclinical evaluation with a sex perspective. Transl Psychiatry. 2022;12:220.","journal-title":"Transl Psychiatry"},{"key":"750_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jchemneu.2019.04.006","volume":"98","author":"GP Silote","year":"2019","unstructured":"Silote GP, Sartim A, Sales A, Eskelund A, Guimar\u00e3es FS, Wegener G, et al. Emerging evidence for the antidepressant effect of Cannabidiol and the underlying molecular mechanisms. J Chem Neuroanat. 2019;98:104\u201316.","journal-title":"J Chem Neuroanat"},{"key":"750_CR12","doi-asserted-by":"publisher","first-page":"pyae064","DOI":"10.1093\/ijnp\/pyae064","volume":"28","author":"Y Miao","year":"2025","unstructured":"Miao Y, Zhao F, Guan W. A novel insight into the antidepressant effect of cannabidiol: possible involvement of the 5-HT1A, CB1, GPR55, and PPARgamma receptors. Int J Neuropsychopharmacol. 2025;28:pyae064.","journal-title":"Int J Neuropsychopharmacol"},{"key":"750_CR13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","volume":"150","author":"A Thomas","year":"2007","unstructured":"Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol. 2007;150:613\u201323.","journal-title":"Br J Pharmacol"},{"key":"750_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"RG Pertwee","year":"2008","unstructured":"Pertwee RG. The diverse CB1 and CB2 receptor Pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol, and delta9-tetrahydrocannabivarin. Br J Pharmacol. 2008;153:199\u2013215.","journal-title":"Br J Pharmacol"},{"key":"750_CR15","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","volume":"172","author":"RB Laprairie","year":"2015","unstructured":"Laprairie RB, Bagher AM, Kelly ME, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172:4790\u2013805.","journal-title":"Br J Pharmacol"},{"key":"750_CR16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3389\/fphar.2017.00744","volume":"8","author":"E Mart\u00ednez-Pinilla","year":"2017","unstructured":"Mart\u00ednez-Pinilla E, Varani K, Reyes-Resina I, Angelats E, Vincenzi F, Ferreiro-Vera C, et al. Binding and signaling studies disclose a potential allosteric site for Cannabidiol in cannabinoid CB2 receptors. Front Pharmacol. 2017;8:744.","journal-title":"Front Pharmacol"},{"key":"750_CR17","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","volume":"134","author":"T Bisogno","year":"2001","unstructured":"Bisogno T, Hanus L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, et al. Molecular targets for Cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of Anandamide. Br J Pharmacol. 2001;134:845\u201352.","journal-title":"Br J Pharmacol"},{"key":"750_CR18","doi-asserted-by":"publisher","first-page":"116742","DOI":"10.1016\/j.bcp.2025.116742","volume":"233","author":"C Alexander","year":"2025","unstructured":"Alexander C, Jeon J, Nickerson K, Hassler S, Vasefi M. CBD and the 5-HT1A receptor: A medicinal and Pharmacological review. Biochem Pharmacol. 2025;233:116742.","journal-title":"Biochem Pharmacol"},{"key":"750_CR19","doi-asserted-by":"publisher","first-page":"111029","DOI":"10.1016\/j.pnpbp.2024.111029","volume":"133","author":"MB Guldager","year":"2024","unstructured":"Guldager MB, Biojone C, da Silva NR, Godoy LD, Joca S. New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol\u2019s antidepressant effect. Prog Neuropsychopharmacol Biol Psychiatry. 2024;133:111029.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"750_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-8-12","volume":"8","author":"SA Wolf","year":"2010","unstructured":"Wolf SA, Bick-Sander A, Fabel K, Leal-Galicia P, Tauber S, Ramirez-Rodriguez G, et al. Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Cell Commun Signal. 2010;8:12.","journal-title":"Cell Commun Signal"},{"key":"750_CR21","doi-asserted-by":"publisher","first-page":"9104","DOI":"10.1523\/JNEUROSCI.20-24-09104.2000","volume":"20","author":"JE Malberg","year":"2000","unstructured":"Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000;20:9104\u201310.","journal-title":"J Neurosci"},{"key":"750_CR22","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.neubiorev.2016.11.012","volume":"72","author":"AL Osborne","year":"2017","unstructured":"Osborne AL, Solowij N, Weston-Green K. A systematic review of the effect of Cannabidiol on cognitive function: relevance to schizophrenia. Neurosci Biobehav Rev. 2017;72:310\u201324.","journal-title":"Neurosci Biobehav Rev"},{"key":"750_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphar.2017.00269","volume":"8","author":"AC Campos","year":"2017","unstructured":"Campos AC, Foga\u00e7a MV, Scarante FF, Joca SRL, Sales AJ, Gomes FV, et al. Plastic and neuroprotective mechanisms involved in the therapeutic effects of Cannabidiol in psychiatric disorders. Front Pharmacol. 2017;8:269.","journal-title":"Front Pharmacol"},{"key":"750_CR24","doi-asserted-by":"publisher","first-page":"115408","DOI":"10.1016\/j.bbr.2024.115408","volume":"480","author":"MSS Lucindo","year":"2025","unstructured":"Lucindo MSS, Albuquerque ALS, Pereira KA, Salgado KDCB, Oliveira LAM, Engel DF, et al. Chronic Cannabidiol administration modulates depressive and cognitive alterations induced by social isolation in male mice. Behav Brain Res. 2025;480:115408.","journal-title":"Behav Brain Res"},{"key":"750_CR25","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. Reporting animal research: explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020;18:e3000411.","journal-title":"PLoS Biol"},{"key":"750_CR26","doi-asserted-by":"publisher","first-page":"117781","DOI":"10.1016\/j.biopha.2024.117781","volume":"182","author":"J Jornet-Plaza","year":"2025","unstructured":"Jornet-Plaza J, Ledesma-Corvi S, Garc\u00eda-Fuster MJ. Characterizing the therapeutical use of ketamine for adolescent rats of both sexes: Antidepressant-like efficacy and safety profile. Biomed Pharmacother. 2025;182:117781.","journal-title":"Biomed Pharmacother"},{"key":"750_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13293-016-0087-5","volume":"7","author":"JB Becker","year":"2016","unstructured":"Becker JB, Prendergast BJ, Liang JW. Female rats are not more variable than male rats: a meta-analysis of neuroscience studies. Biol Sex Differ. 2016;7:34.","journal-title":"Biol Sex Differ"},{"key":"750_CR28","doi-asserted-by":"publisher","first-page":"104962","DOI":"10.1016\/j.neubiorev.2022.104962","volume":"143","author":"AM Kaluve","year":"2022","unstructured":"Kaluve AM, Le JT, Graham BM. Female rodents are not more variable than male rodents: A meta-analysis of preclinical studies of fear and anxiety. Neurosci Biobehav Rev. 2022;143:104962.","journal-title":"Neurosci Biobehav Rev"},{"key":"750_CR29","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1038\/s41386-019-0524-3","volume":"44","author":"AM Beltz","year":"2019","unstructured":"Beltz AM, Beery AK, Becker JB. Analysis of sex differences in pre-clinical and clinical data sets. Neuropsychopharmacology. 2019;44:2155\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"750_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","volume":"23","author":"JF Cryan","year":"2002","unstructured":"Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci. 2002;23:238\u201345.","journal-title":"Trends Pharmacol Sci"},{"key":"750_CR31","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nprot.2012.044","volume":"7","author":"DA Slattery","year":"2012","unstructured":"Slattery DA, Cryan JF. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc. 2012;7:1009\u201314.","journal-title":"Nat Protoc"},{"key":"750_CR32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.euroneuro.2020.10.008","volume":"41","author":"R Garc\u00eda-Cabrerizo","year":"2020","unstructured":"Garc\u00eda-Cabrerizo R, Ledesma-Corvi S, Bis-Humbert C, Garc\u00eda-Fuster MJ. Sex differences in the antidepressant-like potential of repeated electroconvulsive seizures in adolescent and adult rats: regulation of the early stages of hippocampal neurogenesis. Eur Neuropsychopharmacol. 2020;41:132\u201345.","journal-title":"Eur Neuropsychopharmacol"},{"key":"750_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/ijnp\/pyad047","volume":"26","author":"S Ledesma-Corvi","year":"2023","unstructured":"Ledesma-Corvi S, Garc\u00eda-Fuster MJ. Aromatase Inhibition and electroconvulsive seizures in adolescent rats: antidepressant and long-term cognitive sex differences. Int J Neuropsychopharmacol. 2023;26:607\u201315.","journal-title":"Int J Neuropsychopharmacol"},{"key":"750_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neulet.2016.01.018","volume":"615","author":"R Garc\u00eda-Cabrerizo","year":"2016","unstructured":"Garc\u00eda-Cabrerizo R, Garc\u00eda-Fuster MJ. Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence. Neurosci Lett. 2016;615:60\u20135.","journal-title":"Neurosci Lett"},{"key":"750_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1460-9568.2009.07045.x","volume":"31","author":"MJ Garc\u00eda-Fuster","year":"2010","unstructured":"Garc\u00eda-Fuster MJ, Perez JA, Clinton SM, Watson SJ, Akil H. Impact of cocaine on adult hippocampal neurogenesis in an animal model of differential propensity to drug abuse. Eur J Neurosci. 2010;31:79\u201389.","journal-title":"Eur J Neurosci"},{"key":"750_CR36","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1038\/npp.2011.119","volume":"36","author":"MJ Garc\u00eda-Fuster","year":"2011","unstructured":"Garc\u00eda-Fuster MJ, Flagel SB, Mahmood ST, Mayo LM, Thompson RC, Watson SJ, et al. Decreased proliferation of adult hippocampal stem cells during cocaine withdrawal: possible role of the cell fate regulator FADD. Neuropsychopharmacology. 2011;36:2303\u201317.","journal-title":"Neuropsychopharmacology"},{"key":"750_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.neuroscience.2015.07.040","volume":"304","author":"R Garc\u00eda-Cabrerizo","year":"2015","unstructured":"Garc\u00eda-Cabrerizo R, Keller B, Garc\u00eda-Fuster MJ. Hippocampal cell fate regulation by chronic cocaine during periods of adolescent vulnerability: consequences of cocaine exposure during adolescence on behavioral despair in adulthood. Neuroscience. 2015;304:302\u201315.","journal-title":"Neuroscience"},{"key":"750_CR38","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nn1053","volume":"6","author":"ES Rosenzweig","year":"2003","unstructured":"Rosenzweig ES, Redish AD, McNaughton BL, Barnes CA. Hippocampal map realignment and Spatial learning. Nat Neurosci. 2003;6:609\u201315.","journal-title":"Nat Neurosci"},{"key":"750_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2018.07.014","volume":"71","author":"E Hern\u00e1ndez-Hern\u00e1ndez","year":"2018","unstructured":"Hern\u00e1ndez-Hern\u00e1ndez E, Miralles A, Esteban S, Garc\u00eda-Fuster MJ. Improved age-related deficits in cognitive performance and affective-like behavior following acute, but not repeated, 8-OH-DPAT treatments in rats: regulation of hippocampal FADD. Neurobiol Aging. 2018;71:115\u201326.","journal-title":"Neurobiol Aging"},{"key":"750_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/bph.14153","volume":"175","author":"MJ Curtis","year":"2018","unstructured":"Curtis MJ, Alexander S, Cirino G, Docherty JR, George CH, Giembycz MA, et al. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers. Br J Pharmacol. 2018;175:987\u201393.","journal-title":"Br J Pharmacol"},{"key":"750_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1124\/jpet.119.264143","volume":"372","author":"MC Michel","year":"2020","unstructured":"Michel MC, Murphy TJ, Motulsky HJ. New author guidelines for displaying data and reporting data analysis and statistical methods in experimental biology. J Pharmacol Exp Ther. 2020;372:136\u201347.","journal-title":"J Pharmacol Exp Ther"},{"key":"750_CR42","doi-asserted-by":"publisher","first-page":"174000","DOI":"10.1016\/j.pbb.2025.174000","volume":"250","author":"J Dragon","year":"2025","unstructured":"Dragon J, Go\u0142yszny M, Obuchowicz E. Co-treatment with Cannabidiol and Escitalopram in ineffective doses induces antidepressant effect in maternally separated male adolescent rats. Pharmacol Biochem Behav. 2025;250:174000.","journal-title":"Pharmacol Biochem Behav"},{"key":"750_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.09.043","volume":"143","author":"M\u00c1 Luj\u00e1n","year":"2018","unstructured":"Luj\u00e1n M\u00c1, Castro-Zavala A, Alegre-Zurano L, Valverde O. Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus. Neuropharmacology. 2018;143:163\u201375.","journal-title":"Neuropharmacology"},{"key":"750_CR44","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","volume":"231","author":"D Cheng","year":"2014","unstructured":"Cheng D, Low JK, Logge W, Garner B, Karl T. Chronic Cannabidiol treatment improves social and object recognition in double Transgenic APPswe\/PS1\u2206E9 mice. Psychopharmacology. 2014;231:3009\u201317.","journal-title":"Psychopharmacology"},{"key":"750_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuropharm.2018.03.001","volume":"135","author":"MV Foga\u00e7a","year":"2018","unstructured":"Foga\u00e7a MV, Campos AC, Coelho LD, Duman RS, Guimar\u00e3es FS. The anxiolytic effects of Cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling. Neuropharmacology. 2018;135:22\u201333.","journal-title":"Neuropharmacology"},{"key":"750_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pnpbp.2015.06.017","volume":"64","author":"AP Schiavon","year":"2016","unstructured":"Schiavon AP, Bonato JM, Milani H, Guimar\u00e3es FS, Weffort de Oliveira RM. Influence of single and repeated Cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice. Prog Neuropsychopharmacol Biol Psychiatry. 2016;64:27\u201334.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"750_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/cells14020099","volume":"14","author":"U Bright","year":"2025","unstructured":"Bright U, Akirav I. Cannabidiol modulates neuroinflammatory and estrogen-related pathways in a sex-specific manner in a chronic stress model of depression. Cells. 2025;14:99.","journal-title":"Cells"},{"key":"750_CR48","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.pnpbp.2010.11.021","volume":"35","author":"BB Gorzalka","year":"2011","unstructured":"Gorzalka BB, Hill MN. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:1575\u201385.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"750_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.12.002","volume":"138","author":"V Micale","year":"2013","unstructured":"Micale V, Di Marzo V, Sulcova A, Wotjak CT, Drago F. Endocannabinoid system and mood disorders: priming a target for new therapies. Pharmacol Ther. 2013;138:18\u201337.","journal-title":"Pharmacol Ther"},{"key":"750_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00213-010-2097-z","volume":"213","author":"GV Carr","year":"2011","unstructured":"Carr GV, Lucki I. The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology. 2011;213:265\u201387.","journal-title":"Psychopharmacology"},{"key":"750_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","volume":"103","author":"R Linge","year":"2016","unstructured":"Linge R, Jim\u00e9nez-S\u00e1nchez L, Campa L, Pilar-Cu\u00e9llar F, Vidal R, Pazos A, et al. Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT1A receptors. Neuropharmacology. 2016;103:16\u201326.","journal-title":"Neuropharmacology"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00750-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00750-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00750-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:58:33Z","timestamp":1757199513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00750-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["750"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00750-5","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}